Skip to content

A prospective randomized controlled study of foldable balloon therapy for rheogenic retinal detachment

A prospective randomized controlled study of foldable balloon therapy for rheogenic retinal detachment - Prospective randomized controlled study of FCB in the treatment of RRD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095845
Enrollment
Unknown
Registered
2025-01-14
Start date
2025-02-01
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheogenic retinal detachment

Interventions

Experimental group :Foldable vitreous balloon implantation
control grop:vitrectomy

Sponsors

Affiliated Eye Hospital of Shandong University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Those who voluntarily participate and sign the informed consent are willing to comply with the treatment arrangements stipulated in the trial protocol and are willing to follow up on time. 2. Age 18-75 years old, gender unlimited 3. Fundus examination confirmed rheogenic retinal detachment, with the hole located at or behind the equator (1) Horseshoe hole caused by posterior detachment of vitreous body (2) Multiple retinal holes, the distance between the holes <1 quadrant (3) Single or adjacent holes with hiatus <3PD (4) Proliferative vitreoretinopathy (PVR) < Grade B (5) Retinal detachment range <3 quadrants

Exclusion criteria

Exclusion criteria: 1. Combined with macular hole 2. choroidal detachment 3. The serrated edge is broken 4. Traumatic retinal detachment 5. dioptric interstitial opacity, such as combined vitreous hemorrhage and cataract 6. Those assessed by the investigator as likely to affect subject compliance or outcome evaluation

Design outcomes

Primary

MeasureTime frame
Retinal reattachment rate;Best corrected vision;

Secondary

MeasureTime frame
Macular blood flow density;Perioptic disc vascular density;Fixation stability;Light acuity;

Countries

China

Contacts

Public ContactYing Wen

Affiliated Eye Hospital of Shandong University of Traditional Chinese Medicine

wenyingeye@163.com+86 138 0892 1303

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026